RCA
TMO icon

Rowland Carmichael Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Rowland Carmichael Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$311K Sell
668
-31
-4% -$14.5K 0.1% 221
2020
Q3 		$309K Sell
699
-8
-1% -$3.31K 0.12% 191
2020
Q2 		$256K Buy
+707
New +$237K 0.11% 216

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Rowland Carmichael Advisors's TMO Position: Q4 2020 in Review

Rowland Carmichael Advisors reduced its Thermo Fisher Scientific (TMO) stake by 4.4% in Q4 2020, selling an estimated $14.5K and leaving 668 shares worth $311K. The position accounts for 0.1% of the portfolio, ranked #221.

Rowland Carmichael Advisors first reported a position in TMO in Q2 2020 and has held it in 3 quarters since. 2,030 funds tracked by Wall St. Rank hold TMO as of Q4 2020.

  • Rowland Carmichael Advisors held 668 shares of Thermo Fisher Scientific worth $311K as of Q4 2020.
  • Rowland Carmichael Advisors sold 31 Thermo Fisher Scientific shares in Q4 2020, an estimated $14.5K.
  • Thermo Fisher Scientific made up 0.1% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #221 holding.
  • Rowland Carmichael Advisors first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 3 quarters since.
  • 2,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.